Overactive bladder: strategies to ensure treatment compliance and adherence

被引：17
|
作者：
Dhaliwal, Prabhpreet [1 ]
Wagg, Adrian [1 ]
机构：
[1] Univ Alberta, Dept Med, 1-108 Clin Sci Bldg,11350-83 Ave, Edmonton, AB T6G 2P4, Canada
来源：
CLINICAL INTERVENTIONS IN AGING | 2016年 / 11卷
关键词：
overactive bladder; persistence; adherence; URINARY-TRACT SYMPTOMS; QUALITY-OF-LIFE; MEDICATION ADHERENCE; CONTINENCE SOCIETY; IMMEDIATE-RELEASE; EXTENDED-RELEASE; PERSISTENCE; INCONTINENCE; INTERVENTIONS; THERAPY;
D O I：
10.2147/CIA.S69636
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Overactive bladder is a common, debilitating condition for many patients who may benefit from pharmacological management of their condition. However, adherence to medication in this condition is markedly worse than other chronic medical conditions. This review explores what is known about persistence and the factors which influence medication adherence for overactive bladder, those factors that might be modifiable to improve adherence, and the measures the health care provider can take to optimize adherence to therapy and thereby improve treatment outcomes.
引用
收藏
页码：755 / 760
页数：6
相关论文
共 50 条
  • [11] Persistence and compliance with anticholinergic treatment given for overactive bladder in daily clinical practice
    Corcos, J.
    Tamarkina, E.
    Block, B.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 273 - 273
  • [12] Treatment of the overactive bladder
    Wagenlehner, FME
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (03) : 118 - 118
  • [13] Treatment of overactive bladder
    Peschers U.
    Der Gynäkologe, 2017, 50 (3): : 184 - 188
  • [14] Treatment for overactive bladder
    Rothe, P.
    Kalchthaler, M.
    Muehlich, S.
    UROLOGE, 2011, 50 (10): : 1301 - 1305
  • [15] Persistence and compliance with anticholinergic treatment given for overactive bladder in daily clinical practice
    Corcos, Jacques
    Tamarkina, Elena
    Blok, Bertil
    JOURNAL OF UROLOGY, 2007, 177 (04): : 439 - 440
  • [16] Barriers and facilitators to overactive bladder therapy adherence
    Enemchukwu, Ekene A.
    Subak, Leslee L.
    Markland, Alayne
    NEUROUROLOGY AND URODYNAMICS, 2022, 41 (08) : 1983 - 1992
  • [17] Overactive bladder and pain: Management strategies
    Patel B.N.
    Evans R.J.
    Current Urology Reports, 2010, 11 (6) : 379 - 384
  • [18] A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain
    Jameel Nazir
    Zalmai Hakimi
    Florent Guelfucci
    Amine Khemiri
    Francis Fatoye
    Ana María Mora Blázquez
    Marta Hernández González
    BMC Urology, 18
  • [19] A retrospective study of treatment persistence and adherence to mirabegron versus antimuscarinics, for the treatment of overactive bladder in Spain
    Nazir, Jameel
    Hakimi, Zalmai
    Guelfucci, Florent
    Khemiri, Amine
    Fatoye, Francis
    Blazquez, Ana Maria Mora
    Gonzalez, Marta Hernandez
    BMC UROLOGY, 2018, 18
  • [20] Compliance with overactive bladder medications in a managed healthcare organization
    Rieder, Jocelyn
    Tran, Viet
    Stem, Karen
    Chopra, Ashok
    Aboseif, Sherif
    JOURNAL OF UROLOGY, 2008, 179 (04): : 142 - 142
12345